HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Partial remission of hyperprolactinemic amenorrhea after bromocriptine-induced pregnancy.

Abstract
Clinical and/or biological improvement has been observed in 7 out of 17 patients with hyperprolactinemic amenorrhea followed for 6-15 months after the successful outcome of bromocriptine (Parlodel, Sandoz)- induced pregnancy. The ovulatory cycle was resumed in 2 out of these 7 patients (with subsequent spontaneous conception in 1); in 3 others the medroxyprogesterone acetate test became positive. In all cases, post-partum prolactin values were considerably reduced. The possible causes of this improvement are discussed, examining the present data and those in the literature. Regressive lesions, due for example to vascularization defects or hemorrhage occurring in the prolactin-secreting tissue, as a result of the hyperplastic stimulus of estrogens during pregnancy, are suggested as a possible explanation.
AuthorsC Campagnoli, L Belforte, F Massara, C Peris, G M Molinatti
JournalJournal of endocrinological investigation (J Endocrinol Invest) 1981 Jan-Mar Vol. 4 Issue 1 Pg. 85-91 ISSN: 0391-4097 [Print] Italy
PMID7240674 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Bromocriptine
  • Prolactin
Topics
  • Adult
  • Amenorrhea (therapy)
  • Bromocriptine (therapeutic use)
  • Female
  • Humans
  • Ovulation Induction
  • Postpartum Period
  • Pregnancy
  • Prolactin (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: